NORNQ yields 2000000.00% · JNJ yields 2.13%● Live data
📍 NORNQ pulled ahead of the other in Year 1
Combined, NORNQ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NORNQ + JNJ for your $10,000?
Noranda Aluminum Holding Corporation produces and sells primary aluminum, alumina, bauxite, and rolled aluminum coils in the United States. The company's Bauxite segment mines, produces, and sells bauxite used for alumina production. Its Alumina segment refines and converts bauxite into alumina, which is used in the production of primary aluminum; and sells smelter grade alumina and alumina hydrate, or chemical-grade alumina. The company's Primary Aluminum segment produces and sells aluminum products in various forms, such as billets, rods, sow and foundry, and commodity grade sow. Its Flat-Rolled Products segment primarily produces rolled aluminum products, including finstock for use in commercial, residential, and automotive applications; container stock for pre-packaged foods; converter foils for food, drink, agricultural, and industrial products; and transformer windings used as conducting medium. The company sells its products to original equipment manufacturers of air conditioners, transformers, semi-rigid containers, and foil packaging. The company was founded in 2007 and is headquartered in Franklin, Tennessee.
Full NORNQ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.